This is frequently seen as the threshold to approach herd immunity, the level of vaccination coverage that limits spread and protects those who are unable to be vaccinated from infection. ![]() It is important to remember that this total is a sum of projections from vaccine developers and may include optimistic assumptions.Īssuming the market is primarily 2-dose vaccines (Janssen and CanSino are the only 1-dose vaccines currently on the market), about 11 billion doses are needed to vaccinate 70 percent of the world’s population. Our analysis of 2021 projections from Covid-19 vaccine makers indicates that more than 12 billion doses could be produced this year. VACCINE MAKERS PROJECT A GLOBAL TOTAL OF 12 BILLION DOSES OF COVID-19 VACCINE IN 2021 Please contact us with data or corrections that can improve the accuracy of this data set. We hope that by highlighting the data gaps, we will encourage others to join this effort and help to fill in missing data points and bring more clarity to a murky system. It is important to recognize that this data is not comprehensive, as there are still many unknowns, but we are aggregating the information that is available to enable better insights and decisions globally. Read our Issue Brief: Deciphering the Manufacturing Landscape for Covid-19 Vaccines. To help address this challenge, we are now tracking and analyzing publicly available information on manufacturing by vaccine and location. Publicly available information on production is scarce and fragmented, making it difficult for policy- and decision-makers to fully understand the various supply chains involved, take stock of the risks, and take urgent action where it is most needed in this global effort. Countries are looking to production estimates and delivery schedules to understand what they will have and when.ĭespite the importance of manufacturing, the landscape itself is remarkably opaque. Now, as many countries roll out their vaccination campaigns, manufacturing and supply have become critical constraints for global access and equity. In late 2020 and early 2021, purchases were the primary marker of who would get vaccines and who would be left behind. Note that our manufacturing data is up-to-date as of Jand we are not furhter updating the data or webpage content at this time. Download our manufacturing data as part of our vaccine updates here.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |